http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Novavax and Commonwealth of Australia Announce Agreement in Principle for Acquisition of Novavax COVID-19 Vaccine
-
Novavax (NVAX) Appoints Biopharmaceutical Industry Veteran Gregg Alton to Board of Directors
-
Novavax Appoints Biopharmaceutical Industry Veteran Gregg Alton to Board of Directors
-
Novavax Appoints Biopharmaceutical Industry Veteran Gregg Alton to Board of Directors
-
Novavax to Host Conference Call to Discuss Third Quarter Financial and Operating Results on November 9, 2020
-
Novavax to Host Conference Call to Discuss Third Quarter Financial and Operating Results on November 9, 2020
-
Novavax (NVAX) Announces Facility Expansion to Support Global Vaccine Development
-
Novavax Announces Facility Expansion to Support Global Vaccine Development
-
Novavax Announces Facility Expansion to Support Global Vaccine Development
-
Novavax (NVAX) Reports Phase 3 COVID-19 Vaccine Clinical Development Update
-
Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update
-
Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update
-
Novavax to Present COVID-19 Vaccine Data at World Vaccine Congress Europe 2020
-
Novavax to Present COVID-19 Vaccine Data at World Vaccine Congress Europe 2020
-
Novavax to Participate in Upcoming Conferences
-
Novavax to Participate in Upcoming Conferences
-
Novavax to Present COVID-19, Influenza and RSV Candidate Vaccine Data at World Vaccine Congress Washington 2020
-
Novavax to Present COVID-19, Influenza and RSV Candidate Vaccine Data at World Vaccine Congress Washington 2020
-
Endo International (ENDP) Announces Fill-Finish Manufacturing and Services Agreement for Novavax (NVAX) COVID-19 Vaccine Candidate
-
Endo Announces Fill-Finish Manufacturing and Services Agreement for Novavax COVID-19 Vaccine Candidate
-
Gov. Hogan, Novavax’ Erck, & BIO’s Dr. McMurry-Heath Toured Novavax Labs and Discussed Progress on COVID-19 Vaccine
-
Gov. Hogan, Novavax’ Erck, & BIO’s Dr. McMurry-Heath Toured Novavax Labs and Discussed Progress on COVID-19 Vaccine
-
Novavax (NVAX) COVID-19 Vaccine Phase 3 Efficacy Trial Initiated in the U.K.
-
Novavax Initiates Phase 3 Efficacy Trial of COVID-19 Vaccine in the United Kingdom
-
Novavax Initiates Phase 3 Efficacy Trial of COVID-19 Vaccine in the United Kingdom
-
Novavax (NVAX) Announces COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India
-
Novavax Announces COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India, Increasing Novavax’ Global Production Capacity to Over 2 Billion Doses Annually
-
Novavax Announces COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India, Increasing Novavax’ Global Production Capacity to Over 2 Billion Doses Annually
-
Novavax to Participate in Upcoming Investor Conferences
-
Novavax to Participate in Upcoming Investor Conferences
-
Vaccine makers announce pledge, outlining united commitment to uphold integrity of scientific process
-
Biopharma Leaders Unite to Stand With Science
-
Biopharma Leaders Unite to Stand with Science
-
Biopharma Leaders Unite To Stand With Science
-
Biopharma Leaders Unite to Stand with Science
-
Biopharma Leaders Unite to Stand with Science
-
Novavax (NVAX) Announces Publication of Phase 1 Data for COVID-19 Vaccine Candidate in NEJM
-
Novavax Announces Publication of Phase 1 Data for COVID-19 Vaccine Candidate in The New England Journal of Medicine
-
Novavax Announces Publication of Phase 1 Data for COVID-19 Vaccine Candidate in The New England Journal of Medicine
-
Novavax (NVAX), Canada Reach Agreement in Principle to Acquire Novavax' COVID-19 Vaccine
-
Novavax and Canada Reach Agreement in Principle to Acquire Novavax’ COVID-19 Vaccine
-
Novavax and Canada Reach Agreement in Principle to Acquire Novavax’ COVID-19 Vaccine
-
Novavax (NVAX) Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 Vaccin
-
Novavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 Vaccine
-
Novavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 Vaccine
-
Novavax (NVAX) Initiates Efficacy Trial of COVID-19 Vaccine in South Africa
-
Novavax Initiates Efficacy Trial of COVID-19 Vaccine in South Africa
-
Novavax Initiates Efficacy Trial of COVID-19 Vaccine in South Africa
-
Novavax (NVAX), UK Government Announce Collaboration and Purchase Agreement of 60 Million Doses for its COVID-19 Vaccine Candidate
-
Novavax and UK Government Announce Collaboration and Purchase Agreement for Novavax’ COVID-19 Vaccine Candidate

